We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's p... Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. Show more
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel...
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel...
Data demonstrates a 7-day treatment regimen with the pan-coronavirus protease inhibitor ALG-097558 was well tolerated and does not require ritonavir boosting SOUTH SAN FRANCISCO, Calif., April...
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel...
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0381 | -5.24360033031 | 0.7266 | 0.7545 | 0.6537 | 305418 | 0.68528728 | CS |
4 | -0.0666 | -8.8200238379 | 0.7551 | 0.8977 | 0.6537 | 233598 | 0.76290683 | CS |
12 | -0.0748 | -9.7995545657 | 0.7633 | 1.2 | 0.6537 | 378148 | 0.91133702 | CS |
26 | 0.0385 | 5.92307692308 | 0.65 | 1.2 | 0.5438 | 361177 | 0.79010321 | CS |
52 | -0.4415 | -39.0707964602 | 1.13 | 1.22 | 0.5388 | 227227 | 0.81035151 | CS |
156 | -22.4615 | -97.0259179266 | 23.15 | 34.31 | 0.5388 | 260355 | 4.34556362 | CS |
260 | -14.0515 | -95.329036635 | 14.74 | 37.5099 | 0.5388 | 238589 | 5.93664233 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions